Epstein-Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19.
Alessia MatteiLorenzo SchiavoniElisabetta RivaMassimo CiccozziRoberta VeralliAngela UrselliVincenzo CitrinitiAntonio NennaGiuseppe PascarellaFabio CostaRita CataldoFelice Eugenio AgròMassimiliano CarassitiPublished in: Intensive care medicine experimental (2024)
Human Herpesviruses reactivations in critically ill patients with COVID-19 severe Pneumonia are associated with mortality and with a higher risk to develop both VAP and ICU-BSI.
Keyphrases
- epstein barr virus
- diffuse large b cell lymphoma
- endothelial cells
- intensive care unit
- induced pluripotent stem cells
- cardiovascular events
- early onset
- pluripotent stem cells
- mechanical ventilation
- risk factors
- type diabetes
- cardiovascular disease
- coronary artery disease
- herpes simplex virus
- acute respiratory distress syndrome